FdaApplication
NDA 208794
Identifiers
- fda_app_no: NDA208794
Properties
| Property | Value |
|---|---|
| applicant_name | TERSERA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2017-02-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XERMELO | TELOTRISTAT ETIPRATE | EQ 250MG BASE | TABLET;ORAL |
1 product